These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37226762)

  • 1. Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
    Abou Alaiwi S; Roston TM; Marstrand P; Claggett BL; Parikh VN; Helms AS; Ingles J; Lampert R; Lakdawala NK; Michels M; Owens AT; Rossano JW; Saberi S; Abrams DJ; Ashley EA; Semsarian C; Stendahl JC; Ware JS; Miller E; Ryan TD; Russell MW; Day SM; Olivotto I; Vissing CR; Ho CY
    Circulation; 2023 Aug; 148(5):394-404. PubMed ID: 37226762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.
    Marstrand P; Han L; Day SM; Olivotto I; Ashley EA; Michels M; Pereira AC; Wittekind SG; Helms A; Saberi S; Jacoby D; Ware JS; Colan SD; Semsarian C; Ingles J; Lakdawala NK; Ho CY;
    Circulation; 2020 Apr; 141(17):1371-1383. PubMed ID: 32228044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction.
    Yagi N; Seguchi O; Mochizuki H; Kuroda K; Nakajima S; Watanabe T; Yanase M; Tadokoro N; Fukushima S; Fujita T; Fukushima N
    ESC Heart Fail; 2021 Dec; 8(6):5513-5522. PubMed ID: 34708560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.
    Wasserstrum Y; Larrañaga-Moreira JM; Martinez-Veira C; Itelman E; Lotan D; Sabbag A; Kuperstein R; Peled Y; Freimark D; Barriales-Villa R; Arad M
    ESC Heart Fail; 2022 Aug; 9(4):2301-2312. PubMed ID: 35488723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
    Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
    Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Rosmini S; Biagini E; O'Mahony C; Bulluck H; Ruozi N; Lopes LR; Guttmann O; Reant P; Quarta CC; Pantazis A; Tome-Esteban M; Mckenna WJ; Rapezzi C; Elliott PM
    Heart; 2017 Feb; 103(4):300-306. PubMed ID: 27798053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort.
    Russo C; Jin Z; Elkind MS; Rundek T; Homma S; Sacco RL; Di Tullio MR
    Eur J Heart Fail; 2014 Dec; 16(12):1301-9. PubMed ID: 25211239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
    Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of systolic dysfunction in genotyped hypertrophic cardiomyopathy.
    Fujino N; Konno T; Hayashi K; Hodatsu A; Fujita T; Tsuda T; Nagata Y; Kawashiri MA; Ino H; Yamagishi M
    Clin Cardiol; 2013 Mar; 36(3):160-5. PubMed ID: 23197398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
    Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the
    Akhtar MM; Lorenzini M; Cicerchia M; Ochoa JP; Hey TM; Sabater Molina M; Restrepo-Cordoba MA; Dal Ferro M; Stolfo D; Johnson R; Larrañaga-Moreira JM; Robles-Mezcua A; Rodriguez-Palomares JF; Casas G; Peña-Peña ML; Lopes LR; Gallego-Delgado M; Franaszczyk M; Laucey G; Rangel-Sousa D; Basurte M; Palomino-Doza J; Villacorta E; Bilinska Z; Limeres Freire J; Garcia Pinilla JM; Barriales-Villa R; Fatkin D; Sinagra G; Garcia-Pavia P; Gimeno JR; Mogensen J; Monserrat L; Elliott PM
    Circ Heart Fail; 2020 Oct; 13(10):e006832. PubMed ID: 32964742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
    Lakdawala NK; Olivotto I; Day SM; Han L; Ashley EA; Michels M; Ingles J; Semsarian C; Jacoby D; Jefferies JL; Colan SD; Pereira AC; Rossano JW; Wittekind S; Ware JS; Saberi S; Helms AS; Cirino AL; Leinwand LA; Seidman CE; Ho CY
    Circ Genom Precis Med; 2021 Feb; 14(1):e003062. PubMed ID: 33284039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison Between Heart Failure Without Left Ventricular Systolic Dysfunction and Progression to End-Stage in Hypertrophic Cardiomyopathy.
    Nakagawa S; Okada A; Irie Y; Moriuchi K; Amano M; Amaki M; Kanzaki H; Kusano K; Noguchi T; Kitai T; Izumi C
    Circ J; 2024 Aug; 88(9):1472-1477. PubMed ID: 38910134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance.
    Pinamonti B; Merlo M; Nangah R; Korcova R; Di Lenarda A; Barbati G; Sinagra G
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):669-77. PubMed ID: 20216227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
    Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
    J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure.
    Akhtar MM; Lorenzini M; Pavlou M; Ochoa JP; O'Mahony C; Restrepo-Cordoba MA; Segura-Rodriguez D; Bermúdez-Jiménez F; Molina P; Cuenca S; Ader F; Larrañaga-Moreira JM; Sabater-Molina M; Garcia-Alvarez MI; Arantzamendi LG; Truszkowska G; Ortiz-Genga M; Ruiz IS; Nielsen SK; Rasmussen TB; Robles Mezcua A; Alvarez-Rubio J; Eiskjaer H; Gautel M; Garcia-Pinilla JM; Ripoll-Vera T; Mogensen J; Limeres Freire J; Rodríguez-Palomares JF; Peña-Peña ML; Rangel-Sousa D; Palomino-Doza J; Arana Achaga X; Bilinska Z; Zamarreño Golvano E; Climent V; Peñalver MN; Barriales-Villa R; Charron P; Yotti R; Zorio E; Jiménez-Jáimez J; Garcia-Pavia P; Elliott PM;
    JAMA Cardiol; 2021 Aug; 6(8):891-901. PubMed ID: 33978673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Marston NA; Han L; Olivotto I; Day SM; Ashley EA; Michels M; Pereira AC; Ingles J; Semsarian C; Jacoby D; Colan SD; Rossano JW; Wittekind SG; Ware JS; Saberi S; Helms AS; Ho CY
    Eur Heart J; 2021 May; 42(20):1988-1996. PubMed ID: 33769460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.
    Rouskas P; Zegkos T; Ntelios D; Gossios T; Parcharidou D; Papanastasiou CA; Karamitsos T; Vassilikos V; Kouskouras K; Efthimiadis GK
    Hellenic J Cardiol; 2023; 73():8-15. PubMed ID: 36775018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.